Corcept Therapeutics (CORT) Share-based Compensation Growth (5y) (2015 - 2026)
Corcept Therapeutics (CORT) Share-based Compensation Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Corcept Therapeutics | 9.56 Bn | 9.22 Bn | 162.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.93% |
| Dec 31, 2025 | 56.63% |
| Sep 30, 2025 | 233.41% |
| Jun 30, 2025 | 137.77% |
| Mar 31, 2025 | 22.49% |
| Dec 31, 2024 | 12.86% |
| Sep 30, 2024 | 16.08% |
| Jun 30, 2024 | -39.97% |
| Mar 31, 2024 | -15.88% |
| Dec 31, 2023 | 15.83% |
| Sep 30, 2023 | -8.39% |
| Jun 30, 2023 | -24.26% |
| Mar 31, 2023 | -24.34% |
| Dec 31, 2022 | 41.35% |
| Sep 30, 2022 | 33.56% |
| Jun 30, 2022 | 0.59% |
| Mar 31, 2022 | -6.91% |
| Dec 31, 2021 | 63.14% |
| Sep 30, 2021 | 4.67% |
| Jun 30, 2021 | -0.69% |